台灣神隆股份有限公司
台灣神隆股份有限公司（ScinoPharm Taiwan, Ltd.）及其子公司在台灣及國際市場研發、生產銷售原料藥（API）。提供小分子藥物、蛋白藥、生物大分子合成（胜肽與核酸）；並提供 CDMO 委託開發暨製造服務，涵蓋無菌注射劑與臨床製藥諮詢。公司成立於 1997 年，總部位於台灣台南。
今日下跌 1.59%，股價跌破短期均線。該股 RSI(6) 為 43.3，處於中性區間，短線無明顯超買超賣訊號。股價跌破5日、20日、60日、120日均線。KD 指標中性（K=45.7）；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | -119 | 0 | 0 | -119 |
| 09-23 | +31 | 0 | 0 | +31 |
| 09-22 | -32 | 0 | 0 | -32 |
| 09-21 | +16 | 0 | +10 | +26 |
| 09-18 | -321 | 0 | +52 | -269 |
| 09-17 | +373 | 0 | +6 | +379 |
| 09-16 | -98 | 0 | 0 | -98 |
| 09-15 | -51 | 0 | +22 | -29 |
| 09-14 | -80 | 0 | +1 | -79 |
| 09-11 | -437 | 0 | 0 | -437 |
| 09-10 | -273 | 0 | -15 | -289 |
| 09-09 | +52 | 0 | -14 | +38 |
| 09-08 | -2 | 0 | -15 | -17 |
| 09-07 | +183 | 0 | +25 | +208 |
| 09-04 | -30 | 0 | +8 | -22 |
| 09-03 | -15 | 0 | -3 | -18 |
| 09-02 | +55 | 0 | -4 | +51 |
| 09-01 | -38 | 0 | -4 | -42 |
| 08-31 | -44 | 0 | -9 | -53 |
| 08-28 | +14 | 0 | +12 | +26 |
| 08-27 | +104 | 0 | +2 | +106 |
| 08-26 | +19 | 0 | +12 | +31 |
| 08-25 | 0 | 0 | +5 | +5 |
| 08-24 | -100 | 0 | 0 | -100 |
| 08-21 | -107 | 0 | +28 | -79 |
| 08-20 | +205 | 0 | 0 | +205 |
| 08-19 | +17 | 0 | 0 | +17 |
| 08-18 | -24 | 0 | -2 | -26 |
| 08-17 | +308 | 0 | +3 | +311 |
| 08-14 | -321 | 0 | +4 | -317 |
| 08-13 | +30 | 0 | +16 | +46 |
| 08-12 | +38 | 0 | +2 | +40 |
| 08-11 | +72 | 0 | +7 | +79 |
| 08-10 | -148 | 0 | +17 | -131 |
| 08-07 | +384 | 0 | +9 | +393 |
| 08-06 | -962 | 0 | -28 | -990 |
| 08-05 | +193 | 0 | +2 | +195 |
| 08-04 | +17 | 0 | -101 | -84 |
| 08-03 | -186 | 0 | -41 | -227 |
| 07-31 | +104 | 0 | +14 | +118 |
| 07-30 | -12 | 0 | -28 | -40 |
| 07-29 | +349 | 0 | +33 | +382 |
| 07-28 | -90 | 0 | +3 | -88 |
| 07-27 | +29 | 0 | +12 | +41 |
| 07-24 | -102 | 0 | 0 | -102 |
| 07-23 | -52 | 0 | -5 | -57 |
| 07-22 | -76 | 0 | -39 | -115 |
| 07-21 | +55 | 0 | -17 | +38 |
| 07-20 | +116 | 0 | +33 | +149 |
| 07-17 | -322 | 0 | -8 | -330 |
| 07-16 | -101 | 0 | +8 | -93 |
| 07-15 | +446 | 0 | -17 | +429 |
| 07-14 | +87 | 0 | +30 | +117 |
| 07-13 | -77 | 0 | +26 | -51 |
| 07-09 | -25 | 0 | -5 | -30 |
| 07-08 | -14 | 0 | -1 | -15 |
| 07-07 | +339 | 0 | -11 | +328 |
| 07-06 | +99 | 0 | +1 | +100 |
| 07-03 | +501 | 0 | 0 | +501 |
| 07-02 | -275 | 0 | +1 | -274 |
| 07-01 | +18 | 0 | 0 | +18 |
| 06-30 | -79 | 0 | +5 | -74 |
| 06-29 | +325 | 0 | +9 | +334 |
| 06-26 | -148 | 0 | -6 | -154 |
| 06-25 | +17 | 0 | 0 | +17 |
| 06-24 | +276 | 0 | -4 | +272 |
| 06-22 | +24 | 0 | 0 | +24 |
| 06-18 | -276 | 0 | +1 | -276 |
| 06-17 | +317 | 0 | -14 | +303 |
| 06-16 | +57 | 0 | -1 | +56 |
| 06-15 | +328 | 0 | +9 | +337 |
| 06-12 | +359 | 0 | -13 | +346 |
| 06-10 | -38 | 0 | +7 | -31 |
| 06-09 | +68 | 0 | -6 | +62 |
| 06-08 | +107 | 0 | -4 | +103 |
| 06-04 | -67 | 0 | +9 | -58 |
| 06-03 | +154 | 0 | +3 | +157 |
| 06-02 | +62 | 0 | -7 | +55 |
| 06-01 | +244 | 0 | +3 | +247 |
| 05-29 | +197 | 0 | +3 | +200 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/08 | 1.99 億 | +7.5% | -42.2% |
| 2026/07 | 1.85 億 | -25.3% | -7.0% |
| 2026/06 | 2.48 億 | +41.7% | -3.9% |
| 2026/05 | 1.75 億 | -31.3% | -33.2% |
| 2026/04 | 2.55 億 | -21.6% | +12.5% |
| 2026/03 | 3.25 億 | +56.8% | +3.4% |
| 2026/02 | 2.07 億 | +63.3% | +26.3% |
| 2026/01 | 1.27 億 | -74.0% | -38.8% |
| 2025/12 | 4.88 億 | +133.5% | -18.0% |
| 2025/11 | 2.09 億 | -32.7% | -2.1% |
| 2025/10 | 3.11 億 | +75.2% | +36.4% |
| 2025/09 | 1.77 億 | - | -33.3% |